Chemistry:AUTEN-67
From HandWiki
Short description: Chemical compound
 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C23H14N4O6S |
| Molar mass | 474.45 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
AUTEN-67 is an autophagy-enhancing drug candidate that increases autophagic flux in cell lines and in vivo models.[1]
It hampers the progression of neurodegenerative symptoms in a Drosophila model of Huntington's disease.[2] It is developed by Velgene Biotechnology Ltd.
References
- ↑ 1.0 1.1 "AUTEN-67, an autophagy-enhancing drug candidate with potent antiaging and neuroprotective effects". Autophagy 12 (2): 273–86. 2016. doi:10.1080/15548627.2015.1082023. PMID 26312549.
- ↑ "AUTEN-67 (Autophagy Enhancer-67) Hampers the Progression of Neurodegenerative Symptoms in a Drosophila model of Huntington's Disease". Journal of Huntington's Disease 5 (2): 133–47. May 2016. doi:10.3233/JHD-150180. PMID 27163946. http://content.iospress.com/articles/journal-of-huntingtons-disease/jhd150180.
 |  |
